ThermoGenesis Holdings Inc. (THMO) Operating Margin

ThermoGenesis is transforming its business model by shifting toward providing comprehensive CDMO services for the biotechnology sector. The company is scaling the implementation of automated biobanking systems in an effort to increase its presence in diagnostics. Revenues are based on the sale of cryogenic equipment and technical support, which ensures moderate stability of cash flows. The GURU.Markets portal features a chart of operating margin trends, where the latest data point is -63.30.
Metric breakdowns and analytics for thermogenesis.com (THMO)

Rising demand for the automation of biobanks and stem cell processing laboratories directly impacts the cost management efficiency of ThermoGenesis (THMO). This assessment of operating profitability reflects the share of pre-tax and pre-interest profit from core operations relative to total revenue, allowing investors to filter out market noise and determine the real scaling potential of the business.